Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities

Yahya Yaseen; Ammar Kubba; Wurood Shihab; Lubna Tahtamouni

doi:10.3897/pharmacia.69.e86504

Research Article

Pharmacia 69(3): 595-614
https://doi.org/10.3897/pharmacia.69.e86504 (05 Jul 2022)

Other versions:

(Verbatim name)

(Catalog Number)

DES

Invalid DOI was provided, please try again

(10)

(0)

Mansour Nawasreh, Lubna Tahtamouni (2024)
Performance of Green Desymmetrization Methods toward Bioactive Cephalostatin Analogues. Current Medicinal Chemistry 31: 3327.

DOI: 10.2174/0929867330666230508145058

Omeed M. Hassan, Ammar Kubba, Lubna H. Tahtamouni (2023)
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship. Anti-Cancer Agents in Medicinal Chemistry 23: 1336.

DOI: 10.2174/1871520623666230227153449

Imad M. Al-Rubaye, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, Mai F. AlSakhen, Sana I. Kanaan, Khaled M. Saleh, Salem R. Yasin (2024)
In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors. Results in Chemistry 7: 101329.

DOI: 10.1016/j.rechem.2024.101329

Hiba N. Alsaad, Baan M. AL‐Jasani, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, Khaled M. Saleh, Mai F. AlSakhen, Sana I. Kanaan, Salem R. Yasin (2024)
Novel 1,3,4‐oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation. Drug Development Research 85: .

DOI: 10.1002/ddr.22231

Shaker A. Abdul Hussein, Ammar Kubba, Asim A. Balakit, Lubna H. Tahtamouni, Ali H. Abbas (2023)
Design, Synthesis, in silico and in vitro Evaluation of New Combretastatin A-4 Analogs as Antimitotic Antitumor Agents. Medicinal Chemistry 19: 1018.

DOI: 10.2174/1573406419666230530155741

Shaker A. Abdul Hussein, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, Asim A. Balakit, Yahya S. Yaseen, Rehab A. Al‐Hasani (2023)
New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies. Chemistry & Biodiversity 20: .

DOI: 10.1002/cbdv.202201206

Yahya S. Yaseen, Ammar A.R. Mahmood, Ali H. Abbas, Wurood A. Shihab, Lubna H. Tahtamouni (2023)
New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis, In silico Studies, and Anti-proliferative Assessment. Medicinal Chemistry 19: 445.

DOI: 10.2174/1573406419666221219144804

Thamer Alorini, Ahmed N. Al-Hakimi, Ismail Daoud, Fahad Alminderej, Abuzar E. A. E. Albadri, Lotfi Aroua (2023)
Synthesis, characterization, anticancer activity and molecular docking of metal complexes bearing a new Schiff base ligand. Journal of Biomolecular Structure and Dynamics 41: 10969.

DOI: 10.1080/07391102.2023.2191725

Şerife Gökçe Çalişkan (2024)
DFT, Molecular Docking, Bioactivity and ADME Analyses of Vic-dioxim Ligand Containing Hydrazone Group and its Zn(II) Complex. Current Computer-Aided Drug Design 20: 264.

DOI: 10.2174/1573409919666230503094400

Omeed M. Hassan, Ammar A. Razzak Mahmood, Ali H. Hamzah, Lubna H. Tahtamouni (2022)
Design, Synthesis, and Molecular Docking Studies of 5‐Bromoindole‐2‐Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR‐2 Inhibitory Effects. ChemistrySelect 7: .

DOI: 10.1002/slct.202203726

Subscribe to email alerts for current Article's categories